Indo US Bio-Tech Reports Mixed Financial Results Amidst Highest Profit Levels

Feb 11 2025 05:17 PM IST
share
Share Via
Indo US Bio-Tech has announced its financial results for the quarter ending December 2024, highlighting its highest operating profit in five quarters at Rs 5.54 crore. While profitability metrics improved, net sales declined compared to previous quarters, indicating mixed performance in the company's financial health.
Indo US Bio-Tech has recently reported its financial results for the quarter ending December 2024, showcasing a mix of positive and challenging trends. The company achieved its highest operating profit in the last five quarters, reaching Rs 5.54 crore, with an operating profit margin of 23.51%, indicating improved efficiency. Additionally, profit before tax and profit after tax also marked their highest levels in the same period, at Rs 5.00 crore and Rs 5.05 crore, respectively. Earnings per share have similarly reached a peak of Rs 2.52, reflecting enhanced profitability for shareholders.

However, the company faced challenges in net sales, which totaled Rs 23.56 crore, representing a decline compared to the average net sales of the previous four quarters. This negative trend in sales contrasts with the positive performance in profitability metrics.

As a result of these developments, Indo US Bio-Tech has experienced an adjustment in its evaluation, with its score reflecting these recent changes.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News